Riskpilot← Back to searchSign inGet full accessACUS INVEST AS
ASActiveOrg 915460356Leinebakkane 13, 6094 LeinøyBuying and selling of own real estate · NACE 6811Est. 20150 employees
Revenue 2024
NOK 0
EBITDA margin
—
-4% vs 2023
Equity ratio
97.9%
Financial strength
Net profit 2024
NOK 1,3M
+43% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -200K | -4% |
| Net profit | NOK 1,3M | +43% |
| Total assets | NOK 34,8M | -2% |
| Equity | NOK 34,1M | -1% |
| Employees | 0 | — |
Legal name
ACUS INVEST AS
Org number
915460356
Legal form
Aksjeselskap
NACE code
6811 · Buying and selling of own real estate
Founded
1. juni 2015
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Investering i verdipapirer og fast eiendom, samt delta i andre selskap.
Address
Leinebakkane 13, 6094 Leinøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −117 | −215 | −214 | −193 | −200 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −117 | −215 | −214 | −193 | −200 |
| Net financials | 569 | 2 290 | 412 | 1 254 | 1 381 |
| Profit before tax | 452 | 2 075 | 198 | 1 061 | 1 182 |
| Tax | −24 | 162 | 122 | 138 | −138 |
| Net profit | 476 | 1 913 | 76 | 922 | 1 319 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 383 | 29 748 | 28 496 | 35 410 | 34 805 |
| Equity | 28 593 | 27 106 | 27 182 | 34 244 | 34 063 |
| Long-term debt | 1 451 | 1 161 | 999 | 846 | 440 |
| Short-term debt | 339 | 1 481 | 315 | 320 | 302 |
| Total debt | 1 790 | 2 642 | 1 314 | 1 166 | 742 |
EBITDA margin
-19970300.0%
This company
15.8%
Market median
-126394404% vs market
20202024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
20202024
Return on equity
3.9%
This company
18.4%
Market median
-79% vs market
20202024
Net profit margin
131917900.0%
This company
8.1%
Market median
+1628615949% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BS Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ACUS INVEST AS 
Ably Medical AsBoard members of ACUS INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Beate Sævik Leikanger | Chief Executive Officer | 0 companies |
| Jonny Sævik Leikanger | Chairman | 0 companies |